5 Healthcare Stock Earnings Snapshots

MAKO Surgical Corp. (NASDAQ:MAKO) had a loss and missed Wall Street’s expectations, AND came up short on beating the revenue expectation. Adjusted Earnings Per Share increased to $-0.21 in the quarter versus EPS of $-0.28 in the year-earlier quarter. Revenue Rose 26.32% to $24.81 million from the year-earlier quarter.

MAKO Surgical Corp. reported adjusted EPS loss of $0.21 per share. By that measure, the company missed the mean analyst estimate of $-0.19. It missed the average revenue estimate of $24.82 million.

NEW! Discover a new stock idea each week for less than the cost of 1 trade. CLICK HERE for your Weekly Stock Cheat Sheets NOW!

MAKO

Furiex Pharmaceuticals, Inc. (NASDAQ:FURX) delivered a profit and beat Wall Street’s expectations, AND beat the revenue expectation. Adjusted Earnings Per Share increased to $0.82 in the quarter versus EPS of $-0.98 in the year-earlier quarter. Revenue Rose 1384.15% to $39.33 million from the year-earlier quarter.

Furiex Pharmaceuticals, Inc. reported adjusted EPS income of $0.82 per share. By that measure, the company beat the mean analyst estimate of $0.79. It beat the average revenue estimate of $33.42 million.

NEW! Discover a new stock idea each week for less than the cost of 1 trade. CLICK HERE for your Weekly Stock Cheat Sheets NOW!

FURX

ArthroCare Corporation (NASDAQ:ARTC) delivered a profit and missed Wall Street’s expectations, AND came up short on beating the revenue expectation. Adjusted Earnings Per Share decreased 23.08% to $0.3 in the quarter versus EPS of $0.39 in the year-earlier quarter. Revenue Decreased 0.61% to $92.3 million from the year-earlier quarter.

ArthroCare Corporation reported adjusted EPS income of $0.3 per share. By that measure, the company missed the mean analyst estimate of $0.37. It missed the average revenue estimate of $94.41 million.

NEW! Discover a new stock idea each week for less than the cost of 1 trade. CLICK HERE for your Weekly Stock Cheat Sheets NOW!

ARTC

Bio-Rad Laboratories, Inc. (NYSE:BIO) delivered a profit and missed Wall Street’s expectations, AND came up short on beating the revenue expectation. Adjusted Earnings Per Share decreased 37.61% to $0.68 in the quarter versus EPS of $1.09 in the year-earlier quarter. Revenue Rose 2.76% to $499.7 million from the year-earlier quarter.

Bio-Rad Laboratories, Inc. reported adjusted EPS income of $0.68 per share. By that measure, the company missed the mean analyst estimate of $1.06. It missed the average revenue estimate of $506.34 million.

NEW! Discover a new stock idea each week for less than the cost of 1 trade. CLICK HERE for your Weekly Stock Cheat Sheets NOW!

BIO

Tornier N.V. (NASDAQ:TRNX) had a loss and missed Wall Street’s expectations, BUT beat the revenue expectation. Adjusted Earnings Per Share decreased to $-0.17 in the quarter versus EPS of $0.00 in the year-earlier quarter. Revenue Rose 11.07% to $82.7 million from the year-earlier quarter.

Tornier N.V. reported adjusted EPS loss of $0.17 per share. By that measure, the company missed the mean analyst estimate of $-0.10. It beat the average revenue estimate of $81.6 million.

NEW! Discover a new stock idea each week for less than the cost of 1 trade. CLICK HERE for your Weekly Stock Cheat Sheets NOW!

TRNX

Stocks with improving earnings metrics are worthy of your extra attention. In fact, “E = Earnings Are Increasing Quarter-Over-Quarter” is a core component of our CHEAT SHEET investing framework for this very reason. Don’t waste another minute – click here and get our CHEAT SHEET stock picks now.